Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Top Headlines

Limiting health care data collection is a bogus, fake conversation, says Health iQ exec

Rather than limit health care data collection, the industry should focus on ensuring those data sets are used ‘in the most appropriate way,’ according to Health iQ chief commercial officer.

World Courier making multi-million dollar tech investment

World Courier has made a multimillion-dollar investment in its supply chain technology to help meet the expanding needs of the pharmaceutical industry.

Cambrex acquires Avista for $252m, becomes integrated CDMO

Cambrex is set to acquire Avista and enter the market of early stage small molecule development and testing.

Cryoport talks compliance, biopharma expansion, and Brexit

Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Cryoport.

Animal models are less informative than a coin flip, says AAPS speaker

The predictive value of animal models is less than 50%, which makes them less informative than a coin flip, says AAPS speaker – who also argues that clinical trial participants are not fully aware of the risks.

PE firm brings CROs together, putting assay development and testing under one roof

The PE firm Ampersand Capital Partners has acquired Pacific Biomarkers and is merging the CRO with Neomed-Labs to streamline clinical immunology development.

Promotional Features

Content provided by Covance Inc

Mining Real-World Data with Cutting-Edge Analytical Tools

In 1848, the most famous Gold Rush in American history began at Sutter's Mill near present-day Coloma, California, shaping the US economic map forever. In those days, there were no scientific tools to guide prospectors in their search. Sites of previous...

Content provided by Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Virtual and hybrid clinical trials have arrived. Having learnt from pilot projects, pharma companies are systematically incorporating patient-centric services into trials, resulting in a significant minority of today’s studies featuring virtual elements....